By Kiku Steinfeld
Chicago, Feb. 8 – JPMorgan Chase Financial Co. LLC priced $607,000 of 0% uncapped accelerated barrier notes due Jan. 30, 2026 linked to the least performing of the ARK Genomic Revolution ETF and the ARK Innovation ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
If each ETF finishes at or above its initial level, the payout at maturity will be par plus 1.07 times the return of the worst performing ETF.
If any ETF falls but each ETF finishes at or above the 60% barrier level, the payout will be par.
Otherwise, investors will be fully exposed to the decline of the worst performing ETF.
The agent is J.P. Morgan Securities LLC.
Issuer: | JPMorgan Chase Financial Co. LLC
|
Guarantor: | JPMorgan Chase & Co.
|
Issue: | Uncapped accelerated barrier notes
|
Underlying funds: | ARK Genomic Revolution ETF and ARK Innovation ETF
|
Amount: | $607,000
|
Maturity: | Jan. 30, 2026
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If each ETF finishes at or above its initial level, par plus 1.07 times the return of the worst performing ETF; if any ETF falls but all ETFs finish at or above the barrier level, par; otherwise, investors will be fully exposed to the decline of the worst performing ETF
|
Initial ETF levels: | $138.35 for Innovation, $100.70 for Genomic
|
Barrier levels: | $83.01 for Innovation, $60.42 for Genomic; 60% of initial levels
|
Pricing date: | Jan. 27
|
Settlement date: | Feb. 1
|
Agent: | J.P. Morgan Securities LLC
|
Fees: | 1.06631%
|
Cusip: | 48132RA67
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.